Pharmerica Corporation (NYSE:PMC) will post its quarterly earnings results before the market opens on Tuesday, November 7th. Analysts expect Pharmerica Corporation to post earnings of $0.49 per share for the quarter.

Pharmerica Corporation (NYSE:PMC) last announced its earnings results on Wednesday, August 2nd. The company reported $0.47 earnings per share for the quarter, meeting the consensus estimate of $0.47. Pharmerica Corporation had a return on equity of 10.94% and a net margin of 1.05%. The company had revenue of $592.00 million for the quarter, compared to the consensus estimate of $592.96 million. During the same period last year, the business posted $0.47 EPS. The company’s revenue was up 13.9% on a year-over-year basis. On average, analysts expect Pharmerica Corporation to post $1.94 EPS for the current fiscal year and $2.19 EPS for the next fiscal year.

Pharmerica Corporation (NYSE PMC) opened at 29.10 on Tuesday. Pharmerica Corporation has a 52 week low of $19.20 and a 52 week high of $29.50. The firm has a 50 day moving average price of $29.15 and a 200 day moving average price of $26.95. The stock has a market capitalization of $905.62 million, a P/E ratio of 39.43 and a beta of 0.85.

Several equities analysts have recently commented on PMC shares. Zacks Investment Research lowered Pharmerica Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, July 18th. BidaskClub lowered Pharmerica Corporation from a “hold” rating to a “sell” rating in a report on Monday, July 31st. KeyCorp lowered Pharmerica Corporation to an “overweight” rating in a report on Wednesday, August 2nd. Barrington Research lowered Pharmerica Corporation from an “outperform” rating to an “underperform” rating in a report on Thursday, August 3rd. Finally, UBS AG reaffirmed a “neutral” rating and set a $29.25 target price (up from $26.00) on shares of Pharmerica Corporation in a report on Thursday, August 3rd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $30.50.

COPYRIGHT VIOLATION NOTICE: “Pharmerica Corporation (PMC) Scheduled to Post Earnings on Tuesday” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/31/pharmerica-corporation-pmc-scheduled-to-post-earnings-on-tuesday.html.

Pharmerica Corporation Company Profile

Earnings History for Pharmerica Corporation (NYSE:PMC)

Receive News & Ratings for Pharmerica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmerica Corporation and related companies with MarketBeat.com's FREE daily email newsletter.